The most recent development in cancer research brings humanity a step closer to resolving our constant battle with health issues. A few biochemists in France have now come up with some great news for all cancer patients and everyone who’s dreading the onset of cancer at some point in their lives. Unusually overactive protein kinase has been implicated in many cancers and the recent increase in research about this has led to the discovery of Polyoxometalates, a synthetic molecular structure made from molybdenum, tungsten and oxygen. Polyoxometalates (metals & oxygen) are powerful CK2 (kinase protein which overacts in cancer conditions) inhibitors, slowing the development of carcinogenic cells. CK2 belongs to the Phosphorylation enzymes group, significant contributors to cancer growths.

So far, the Polyoxometalates are the most powerful CK2 inhibitors found by scientific research and development. They work at extremely low concentrations (nanomolar concentrates). Also, it’s action method is unique in comparison to other cancer fighting drugs. They don’t bind to the CK2 enzyme’s active site. The new discovery has opened the way to further research on the possibilities, adverse effects and the acceptability of this wonder drug.

This entry was posted on Thursday, July 31st, 2008 at 5:06 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.